[引用][C]Anticoagulants as Potential SARS-CoV-2 Mpro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies
At present therapeutic options for severe acute respiratory syndrome coronavirus-2 (SARS- CoV-2) are very limited. We designed and synthesized three sets of small molecules using …
The persistent evolution of drug-resistant influenza strains represents a global concern. The innovation of new treatment approaches through drug screening strategies and investigating …
In late December 2019, a novel coronavirus, namely severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), escaped the animal–human interface and emerged as an …
Investigating bicelles as an oral drug delivery system and exploiting their structural benefits can pave the way to formulate hydrophobic drugs and potentiate their activity. Herein, the …
Docking analysis of propolis's natural compound was successfully performed against SARS- CoV-2 main protease (Mpro) and spike protein subunit 2 (S2). Initially, the propolis's protein …
NGM Attallah, AH El-Kadem, WA Negm, E Elekhnawy… - Pharmaceuticals, 2021 - mdpi.com
The global emergence of the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has focused the entire world's attention toward …